tetrazoles - CISMeF

Preferred Label : tetrazoles;

Wikipedia automatic translation : Tetrazole;

Wikipedia link : https://en.wikipedia.org/wiki/Tetrazole;

Is substance : O;

Details

Origin ID

D013777;

UMLS CUI

C0039703;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- 1h-tetrazole [Substance BNPC]
- Tetrazole (substance) [SNOMED CT concept]
Record concept(s)
- tetrazoles [MeSH concept]
Related MeSH Supplementary Concept(s)
- ((E)-(1-(4-ethoxyphenyl)-1H-tetrazol-5-yl)iminomethyl)dimethylamine [MeSH Supplementary Concept]
- (2-fluoromethoxy-5-(5-trifluoromethyltetrazol-1-yl)benzyl)(2-phenylpiperidin-3-yl)amine [MeSH Supplementary Concept]
- (2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine [MeSH Supplementary Concept]
- (2R,3R,4S,5R)-2-(6-amino-2-(((1S)-2-hydroxy-1-(phenylmethyl)ethyl)amino)-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol [MeSH Supplementary Concept]
- (5,6,7,8-tetrahydronaphthalen-1-yl)-(2-(1H-tetrazol-5-yl)phenyl)amine [MeSH Supplementary Concept]
- (5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid [MeSH Supplementary Concept]
- (5-(3-thienyl)tetrazol-1-yl)acetic acid [MeSH Supplementary Concept]
- (tetrazol-5-yl)glycine [MeSH Supplementary Concept]
- 1,3,5-benzenetristetrazolate [MeSH Supplementary Concept]
- 1,3-bis(tetrazol-5-yl)triazenate [MeSH Supplementary Concept]
- 1,6-bis(4,7-diaza-6-methyl-5-oxo-3-((2-((5-(phenylthio)tetrazol-1-yl)methyl)pyrrolidin-1-yl)carbonyl)octyloxy)-2,4-hexadiyne [MeSH Supplementary Concept]
- 1-((1H-benzimidazol-2-yl)methyl)-1H-tetrazole [MeSH Supplementary Concept]
- 1-((ethoxycarbonyl)oxy)ethyl 2-butyl-4-((3,3-dimethylacryloyl)methylamino)-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylate [MeSH Supplementary Concept]
- 1-(1-(2H-tetrazol-5-ylmethyl)-1H-indol-3-yl)ethanone [MeSH Supplementary Concept]
- 1-(2,4,6-triisopropylbenzenesulfonyl)-5-(pyridin-2-yl)tetrazolide [MeSH Supplementary Concept]
- 1-(2-(1H-1,2,3,4-tetrazol-5-yl)ethyl)-5,7-dimethoxy-3-(4-methoxyphenyl)-1,2-dihydro-2-quinolinone [MeSH Supplementary Concept]
- 1-(3,4,5-trimethoxyphenyl)-5-(4-ethoxyphenyl)-1H-tetrazole [MeSH Supplementary Concept]
- 1-(3,5-bis(trifluoromethyl)phenyl)-3-(4-bromo-2-(1H-tetrazol-5-yl)phenyl)thiourea [MeSH Supplementary Concept]
- 1-(3,5-bis-trifluoromethylphenyl)-3-(2,4-dibromo-6-(1H-tetrazol-5-yl)phenyl)urea [MeSH Supplementary Concept]
- 1-(3-(2-chlorophenoxy)benzyl)-4-(5-chloro-2-(1H-tetrazol-5-yl)phenyl)piperidin-4-ol [MeSH Supplementary Concept]
- 1-(3-methoxyphenyl)-4-methyl-1H-tetrazole-5(4H)-thione [MeSH Supplementary Concept]
- 1-(4-bromophenyl)-5-mercapto-1,2,3,4-tetrazole [MeSH Supplementary Concept]
- 1-(4-chlorophenyl)tetrazole-2-thione [MeSH Supplementary Concept]
- 1-(4-nitrophenyl)-1H-tetrazol-5-amine [MeSH Supplementary Concept]
- 1-(5-chloroindol-3-yl)-3-hydroxy-3-(2H-tetrazol-5-yl)propenone [MeSH Supplementary Concept]
- 1-(tert-butyl)tetrazolyl sulfone [MeSH Supplementary Concept]
- 1-(tetrazol-5-yl)ethanol [MeSH Supplementary Concept]
- 1-N-methyl-5-thiotetrazole [MeSH Supplementary Concept]
- 1-allyl-2-tetrazoline-5-thione [MeSH Supplementary Concept]
- 1-benzyl-3-pentyl-2-(6-(1H-tetrazol-5-ylmethoxy)naphthalen-2-yl)-1H-indole [MeSH Supplementary Concept]
- 1-butyl-5-(4-(2'-carboxyphenyl)benzyl)tetrazole [MeSH Supplementary Concept]
- 1-cyclohexyl-4-(1-phenyl-5-tetrazolyl)thio-1-butanone [MeSH Supplementary Concept]
- 1-methyl-4-phenyl-1H-tetrazole-5(4H)-thione [MeSH Supplementary Concept]
- 1-methyl-5-(methyldithio)-1H-tetrazole [MeSH Supplementary Concept]
- 1-phenyl-5-mercaptotetrazole [MeSH Supplementary Concept]
- 1H-tetrazole [MeSH Supplementary Concept]
- 2,4,6-triisopropylbenzenesulfonyltetrazole [MeSH Supplementary Concept]
- 2,4,6-tris(1-phenyl-1H-tetrazolylsulfanylmethyl)mesitylene [MeSH Supplementary Concept]
- 2-((4-chlorobenzyl)thio)-4-((1-methyl-1H-tetrazol-5-yl)thio)-6-(3,4,5-trimethoxyphenyl)pyrimidine-5-carbonitrile [MeSH Supplementary Concept]
- 2-(1H-tetrazol-5-yl)-4,5-dihydro-4-oxo-indenopyran [MeSH Supplementary Concept]
- 2-(1H-tetrazol-5-yl)acetic acid [MeSH Supplementary Concept]
- 2-(2,3,3-triiodoallyl)-2H-tetrazole [MeSH Supplementary Concept]
- 2-(2-(3-(pyridin-3-yloxy)phenyl)-2H-tetrazol-5-yl)pyridine [MeSH Supplementary Concept]
- 2-(3'-(1H-tetrazol-5-yl) bicyclo(1.1.1)pent-1-yl)glycine [MeSH Supplementary Concept]
- 2-(3-(tetrazolyl)propyl)-1,25-dihydroxy-19-norvitamin D3 [MeSH Supplementary Concept]
- 2-(4-((2)-2-(((2)-2-((tert-butoxycarbonyl)amino)-3-phenylpropanoyl)amino)-3-oxo-3-(pentylamino)propyl)-2-(1(2)H-tetrazol-5-yl)phenoxy)acetic acid [MeSH Supplementary Concept]
- 2-(5-(1-tetrazolylmethyl)thien-3-yl)-N-(2-(mercaptomethyl)-4-(phenylbutyrylglycine)) [MeSH Supplementary Concept]
- 2-4-(3-(1H-1,2,3,4-tetraazol-5-yl)propoxy)phenethyl-1,3-isoindolinedione [MeSH Supplementary Concept]
- 2-amino-3-(3-hydrox-5(2-methyl-2H-tetrazol-5-yl)isoxazol-4-yl)propionic acid [MeSH Supplementary Concept]
- 2-amino-3-(3-hydroxy-5-(2-benzyl-2H-5-tetrazolyl)-4-isoxazolyl)propionic acid [MeSH Supplementary Concept]
- 2-butyl-4-((3,3-dimethylacryloyl)methylamino)-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid [MeSH Supplementary Concept]
- 2-butyl-5-methoxymethyl-6-(1-oxopyridin-2-yl)-3-((2'-(1H-tetrazol-5-yl)bipohenyl-4-yl)methyl)-3H-imidazo(4,5-b)pyridine [MeSH Supplementary Concept]
- 2-butyl-5-methyl-6-(pyridine-3-yl)-3-(2'-(1H-tetrazole-5-yl)-biphenyl-4-ylmethyl)-3H-imidazo(4,5-b)pyridine [MeSH Supplementary Concept]
- 2-butyl-5-styryl-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl)-1H-benzoimidazole-6-carboxylic acid methyl ester [MeSH Supplementary Concept]
- 2-butyl-6-hydroxy-3-(2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl)-3H-quinazolin-4-one [MeSH Supplementary Concept]
- 2-butyl-6-styryl-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl)-1H-benzoimidazole-5-carboxylic acid methyl ester [MeSH Supplementary Concept]
- 2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5-acetamide [MeSH Supplementary Concept]
- 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)benzimidazole [MeSH Supplementary Concept]
- 2-ethyl-4-((2'-(1H-tetrazol-5-yl)-4-biphenylyl)thio)-1,5-naphthyridine [MeSH Supplementary Concept]
- 2-hydroxy-3-propyl-4-(6-(tetrazol-5-yl)hexyloxy)acetophenone [MeSH Supplementary Concept]
- 2-methyl-4-((2'-(1H-tetrazol-5-yl)-4-biphenylyl)thio)quinoline [MeSH Supplementary Concept]
- 2-methylsulfanyl-3-(2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl)-3H-quinazolin-4-one [MeSH Supplementary Concept]
- 2-tert-butyl-5-(2-pyridyl)-2H-tetrazole [MeSH Supplementary Concept]
- 3,4-dehydrocilostazol [MeSH Supplementary Concept]
- 3,6-bis(1H-1,2,3,4-tetrazol-5-ylamino)-1,2,4,5-tetrazine [MeSH Supplementary Concept]
- 3-((5-(benzylthio)-1H-tetrazol-1-yl)methyl)-2-chloro-6-fluoroquinoline [MeSH Supplementary Concept]
- 3-((5-(benzylthio)-2H-tetrazol-2-yl)methyl)-6-bromo-2-chloroquinoline [MeSH Supplementary Concept]
- 3-((5-benzyl-2H-tetrazol-2-yl)methyl)-6-bromo-2-chloroquinoline [MeSH Supplementary Concept]
- 3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydrocyclopentapyrazole [MeSH Supplementary Concept]
- 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinone [MeSH Supplementary Concept]
- 3-(2-(1H-tetrazol-5-yl)ethyl)-5,5-dimethylimidazolidine-2,4-dione [MeSH Supplementary Concept]
- 3-(3-(4-(4-(2H-tetrazole-5-yl)phenoxy)butoxy)-4-methoxyphenyl)-1-cycloheptyl-4,4-dimethyl-1H-pyrazol-5(4H)-one [MeSH Supplementary Concept]
- 3-(3-fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl)-4-methylpyridine [MeSH Supplementary Concept]
- 3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methylpyridine [MeSH Supplementary Concept]
- 3-(5-(2,3-dichlorophenyl)tetrazol-1-ylmethyl)pyridine [MeSH Supplementary Concept]
- 3-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitrile [MeSH Supplementary Concept]
- 3-aminopropyl-5-tetrazole [MeSH Supplementary Concept]
- 3-methyl-5-(5-(pyridin-2-yl)-2H-tetrazol-2-yl)benzonitrile [MeSH Supplementary Concept]
- 3-tetrazolylmethyl-3-hydroxy-oxindole [MeSH Supplementary Concept]
- 4-(1H-tetrazol-5-yl)-N-(4-(1H-tetrazol-5-yl)phenyl)benzamide [MeSH Supplementary Concept]
- 4-(2-oxo-3-(1H-tetrazol-5-yl)-2H-chromen-8-yloxy)butyric acid [MeSH Supplementary Concept]
- 4-(5-(4-chlorophenyl)-2H-tetrazol-2-yl)butan-2-ol [MeSH Supplementary Concept]
- 4-(5-methanesulfonyl-(1,2,3,4)tetrazol-1-yl)-phenol [MeSH Supplementary Concept]
- 4-(hydroxybutyl)carbamic acid 2-(5-(1-(2-amino-2-methylpropionylamino)-2-benzyloxyethyl)tetrazol-1-yl)ethyl ester [MeSH Supplementary Concept]
- 4-butyl-N,N-bis((2-(2H-tetrazol-5-yl)biphenyl-4-yl))methyl [MeSH Supplementary Concept]
- 4-oxo-4H-chromene-2-carboxylic acid (2-(2-(4-(2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl)-phenyl)-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl)amide [MeSH Supplementary Concept]
- 5,5'-dithiobis(1-methyltetrazole) [MeSH Supplementary Concept]
- 5-(1-(2-pyrrolidinylcarbonyl)amino-3-methylbutyl)-2-tetrazolylacetamide [MeSH Supplementary Concept]
- 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole [MeSH Supplementary Concept]
- 5-(1H-tetrazol-1-yl)-1,2,4-triazole [MeSH Supplementary Concept]
- 5-(2-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethylamino)propyl)-5-(1H-tetrazol-5-yl)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene-2,8-dicarboxylic acid bisdimethylamide [MeSH Supplementary Concept]
- 5-(2-ethyl-2H-tetrazol-5-yl)-2-(3-fluorophenyl)-1,3-thiazol-4-ol [MeSH Supplementary Concept]
- 5-(3,5-dichloro-4-((5-(3-methyl-5-isoxazolyl)pentyl)oxy)phenyl)-2-methyl-2H-tetrazole [MeSH Supplementary Concept]
- 5-(3-(6-(5-methyl-2-phenyl-4-oxazolyl-methoxy)-3-pyridyl)propyl)-1H-tetrazole [MeSH Supplementary Concept]
- 5-(3-pyridyl)tetrazole [MeSH Supplementary Concept]
- 5-(4-(3,4-dichloro-2-propylphenoxy)butyl)-1H-tetrazole [MeSH Supplementary Concept]
- 5-(4-(phenylmethoxy)phenyl)-2-(2-cyanoethyl)tetrazole [MeSH Supplementary Concept]
- 5-(5-nitropyridin-2-yldithio)-1-phenyl-1H-tetrazole [MeSH Supplementary Concept]
- 5-(benzylthio)-1-cylopentyl-1H-tetrazole [MeSH Supplementary Concept]
- 5-(pentadec-8-enyl)-2H-tetrazole [MeSH Supplementary Concept]
- 5-(pyrrolidin-2-yl)tetrazole [MeSH Supplementary Concept]
- 5-amino-1H-tetrazole [MeSH Supplementary Concept]
- 5-butyl-1-(4-(2'-carboxyphenyl)benzyl)tetrazole [MeSH Supplementary Concept]
- 5-diazo-1H-tetrazole [MeSH Supplementary Concept]
- 5-ethoxy-1-phenyl-1H-tetrazole [MeSH Supplementary Concept]
- 5-mercaptomethyltetrazole [MeSH Supplementary Concept]
- 5-methylthiotetrazole [MeSH Supplementary Concept]
- 5-n-butyl-4-(4-(2-(1H-tetrazol-5-yl)-1H-pyrrol-1-yl)phenylmethyl)-2,4-dihydro-2-(2,6-dichlorophenyl)-3H-1,2,4-triazol-3-one [MeSH Supplementary Concept]
- 5-nitro-2-nitratomethyl-1,2,3,4-tetrazole [MeSH Supplementary Concept]
- 5-nitrotetrazole [MeSH Supplementary Concept]
- 6-(4-chlorophenoxy)tetrazolo(5,1-a)phthalazine [MeSH Supplementary Concept]
- 6-(dimethylamino)-N-(1H-tetrazol-5-yl)-2-pyrazinecarboxamide [MeSH Supplementary Concept]
- 6-chloro-8-(N,N-dimethylaminosulfonylmethyl)-1,2,3,4-tetrazolo-(1,5-b)pyridazine [MeSH Supplementary Concept]
- 6-trifluoromethyl-3H-benzoimidazole-4-carboxylic acid (3-(1H-tetrazol-5-yl)-phenyl)amide [MeSH Supplementary Concept]
- 606A compound [MeSH Supplementary Concept]
- 6a-hydroxymethyl glutarylsecoisolariciresinol diglucoside [MeSH Supplementary Concept]
- 7919469 compound [MeSH Supplementary Concept]
- 8-quinolinesulfonyltetrazide [MeSH Supplementary Concept]
- 9-bromo-5-morpholino-tetrazole(1,5-c)quinazoline [MeSH Supplementary Concept]
- A 81988 [MeSH Supplementary Concept]
- A-839977 [MeSH Supplementary Concept]
- AM 6701 [MeSH Supplementary Concept]
- ARC 118925XX [MeSH Supplementary Concept]
- AS 35 [MeSH Supplementary Concept]
- ATA-3 (tetrazole) [MeSH Supplementary Concept]
- Acinetobacter baumannii efflux pump inhibitor 2 [MeSH Supplementary Concept]
- BAY 10-6735 [MeSH Supplementary Concept]
- BHDPC compound [MeSH Supplementary Concept]
- BMS 180431-09 [MeSH Supplementary Concept]
- BMS 180560 [MeSH Supplementary Concept]
- BMS 183920 [MeSH Supplementary Concept]
- BMY 21950 [MeSH Supplementary Concept]
- C1632 [MeSH Supplementary Concept]
- CAY10598 [MeSH Supplementary Concept]
- CGP 33304 [MeSH Supplementary Concept]
- CGP 35949 [MeSH Supplementary Concept]
- CGP 45688 [MeSH Supplementary Concept]
- CGP 48369 [MeSH Supplementary Concept]
- CGS 26303 [MeSH Supplementary Concept]
- CGS 26393 [MeSH Supplementary Concept]
- CGS 31447 [MeSH Supplementary Concept]
- CGS 34043 [MeSH Supplementary Concept]
- CGS 34753 [MeSH Supplementary Concept]
- CI 922 [MeSH Supplementary Concept]
- CI 949 [MeSH Supplementary Concept]
- CI 959 [MeSH Supplementary Concept]
- CI 996 [MeSH Supplementary Concept]
- CL 329167 [MeSH Supplementary Concept]
- CV 11194 [MeSH Supplementary Concept]
- Cenobamate [MeSH Supplementary Concept]
- DA 7157 [MeSH Supplementary Concept]
- DMP 811 [MeSH Supplementary Concept]
- DPC11870-11 [MeSH Supplementary Concept]
- DRL-17822 [MeSH Supplementary Concept]
- DuP 167 [MeSH Supplementary Concept]
- DuP 532 [MeSH Supplementary Concept]
- EXP 063 [MeSH Supplementary Concept]
- EXP 985 [MeSH Supplementary Concept]
- EXP3312 [MeSH Supplementary Concept]
- EXP3880 [MeSH Supplementary Concept]
- EXP3892 [MeSH Supplementary Concept]
- F2 protease inhibitor [MeSH Supplementary Concept]
- GR 117289 [MeSH Supplementary Concept]
- GR143330X [MeSH Supplementary Concept]
- GW78415X [MeSH Supplementary Concept]
- HBF 0259 [MeSH Supplementary Concept]
- HN 65021 [MeSH Supplementary Concept]
- HSR 6071 [MeSH Supplementary Concept]
- JNJ4796 [MeSH Supplementary Concept]
- KD3 671 [MeSH Supplementary Concept]
- KKL-55 [MeSH Supplementary Concept]
- KP 136 [MeSH Supplementary Concept]
- KP372-1 [MeSH Supplementary Concept]
- KR 30988 [MeSH Supplementary Concept]
- KR 31080 [MeSH Supplementary Concept]
- KR-31543 [MeSH Supplementary Concept]
- KRH 594 [MeSH Supplementary Concept]
- KT3 671 [MeSH Supplementary Concept]
- L 158809 [MeSH Supplementary Concept]
- L 159906 [MeSH Supplementary Concept]
- L 368935 [MeSH Supplementary Concept]
- L 692429 [MeSH Supplementary Concept]
- L 692585 [MeSH Supplementary Concept]
- L 770644 [MeSH Supplementary Concept]
- L-902688 [MeSH Supplementary Concept]
- L-N6-(1-iminoethyl)lysine-5-tetrazole-amide [MeSH Supplementary Concept]
- LR-B 057 [MeSH Supplementary Concept]
- LU 25-109-T [MeSH Supplementary Concept]
- LY 170198 [MeSH Supplementary Concept]
- LY 170680 [MeSH Supplementary Concept]
- LY 171883 [MeSH Supplementary Concept]
- LY 203647 [MeSH Supplementary Concept]
- LY 233053 [MeSH Supplementary Concept]
- LY 233536 [MeSH Supplementary Concept]
- LY 245769 [MeSH Supplementary Concept]
- LY 246492 [MeSH Supplementary Concept]
- LY 255283 [MeSH Supplementary Concept]
- LY 280748 [MeSH Supplementary Concept]
- LY 290324 [MeSH Supplementary Concept]
- LY 294486 [MeSH Supplementary Concept]
- LY 306669 [MeSH Supplementary Concept]
- LY2318912 [MeSH Supplementary Concept]
- MBX-2982 [MeSH Supplementary Concept]
- ME 3221 [MeSH Supplementary Concept]
- MEN91507 [MeSH Supplementary Concept]
- ML279 compound [MeSH Supplementary Concept]
- N,N'-(2,6-pyridinediyl)bis(1H-tetrazole-5-carboxamide) [MeSH Supplementary Concept]
- N,N-dimethyl-5-(4-phenoxyphenyl)-2H-tetrazole-2-carboxamide [MeSH Supplementary Concept]
- N-(1-oxo-4-hydroxypentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-L-valine [MeSH Supplementary Concept]
- N-(2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl)-N-isobutylpentanamide [MeSH Supplementary Concept]
- N-(2,6-dimethylphenyl)-2-(N-(2-furylmethyl)(4-(1,2,3,4-tetraazolyl)phenyl)carbonylamino)-2-(4-hydroxy-3-methoxyphenyl)acetamide [MeSH Supplementary Concept]
- N-(2-((2-hydroxy-2-(3-pyridyl)ethyl)aminoethyl)phenyl)-4-(4-(3-cyclopentylpropyl)-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)benzenesulfonamide [MeSH Supplementary Concept]
- N-(2-carboxamido-3-methoxyphenyl)-1H-tetrazole-5-carboxamide [MeSH Supplementary Concept]
- N-(3,5-dichlorophenyl)-N'-(2-(1H-tetrazol-5-yl)biphenyl-4-yl-4'-carboxylic acid dimethylamide)urea [MeSH Supplementary Concept]
- N-(3-((1-tert-butyl-1H-tetrazol-5-yl)(pyrrolidin-1-yl)methyl)phenyl)-7-chloroquinolin-4-amine [MeSH Supplementary Concept]
- N-(3-(3-(piperidinomethyl)phenoxy)propyl)-4-(1-methyl-1H-tetrazol-5-ylthio)butanamide [MeSH Supplementary Concept]
- N-(3-(4-methylpiperazin-1-yl)-2-cyanophenyl)-1H-tetrazole-5-carboxamide [MeSH Supplementary Concept]
- N-(3-(5-(1H-tetrazol))pheny)-2-(4-isobutylphenyl)propionamide [MeSH Supplementary Concept]
- N-(3-bromophenyl)-N'-(4-bromo-2-(1H-tetrazol-5-yl)phenyl)urea [MeSH Supplementary Concept]
- N-(4-((2-chloroethanimidoyl)amino)-1-(2-tert-butyl-2H-tetrazol- 5-yl)butyl)biphenyl-4-carboxamide [MeSH Supplementary Concept]
- N-tetrazol-5-yl-9-oxo-9H-xanthene-2-sulfonamide [MeSH Supplementary Concept]
- N53736 [MeSH Supplementary Concept]
- NB 2030 [MeSH Supplementary Concept]
- NID525 [MeSH Supplementary Concept]
- NPD-001 [MeSH Supplementary Concept]
- NS 3623 [MeSH Supplementary Concept]
- NS13558 [MeSH Supplementary Concept]
- PCC0208009 [MeSH Supplementary Concept]
- PF 376304 [MeSH Supplementary Concept]
- PF152 compound [MeSH Supplementary Concept]
- RG 12525 [MeSH Supplementary Concept]
- RG 7152 [MeSH Supplementary Concept]
- RMT5265 [MeSH Supplementary Concept]
- S 18523 [MeSH Supplementary Concept]
- SA 103 [MeSH Supplementary Concept]
- SC 51316 [MeSH Supplementary Concept]
- SK 549 [MeSH Supplementary Concept]
- SKF-32802 [MeSH Supplementary Concept]
- SL 910102-90 DL [MeSH Supplementary Concept]
- ST044643 [MeSH Supplementary Concept]
- TA 606 [MeSH Supplementary Concept]
- TAK 456 [MeSH Supplementary Concept]
- TH 142177 [MeSH Supplementary Concept]
- U 97018 [MeSH Supplementary Concept]
- UP 221-78 [MeSH Supplementary Concept]
- UP 269-6 [MeSH Supplementary Concept]
- UR 7280 [MeSH Supplementary Concept]
- VP-14637 [MeSH Supplementary Concept]
- VT-1129 [MeSH Supplementary Concept]
- VT-1161 [MeSH Supplementary Concept]
- VT-1598 [MeSH Supplementary Concept]
- WAY-140312 [MeSH Supplementary Concept]
- WIN 58768 [MeSH Supplementary Concept]
- WIN 61209 [MeSH Supplementary Concept]
- WIN 61605 [MeSH Supplementary Concept]
- WIN 68934 [MeSH Supplementary Concept]
- WL 110547 [MeSH Supplementary Concept]
- WY 49451 [MeSH Supplementary Concept]
- YM 158 [MeSH Supplementary Concept]
- abbott 81282 [MeSH Supplementary Concept]
- acitazanolast [MeSH Supplementary Concept]
- alpha-amino phenylalanine tetrazole [MeSH Supplementary Concept]
- alpha-methyl-4-tetrazolylphenylglycine [MeSH Supplementary Concept]
- andolast [MeSH Supplementary Concept]
- azosemide [MeSH Supplementary Concept]
- benzimidazole-N-biphenyltetrazole [MeSH Supplementary Concept]
- brifentanil [MeSH Supplementary Concept]
- butyl 3-(1H-tetrazol-5-yl)oxanilate [MeSH Supplementary Concept]
- candesartan [MeSH Supplementary Concept]
- candesartan cilexetil [MeSH Supplementary Concept]
- clazosentan [MeSH Supplementary Concept]
- dasolampanel etibutil [MeSH Supplementary Concept]
- eflumast [MeSH Supplementary Concept]
- embusartan [MeSH Supplementary Concept]
- enoltasosartan [MeSH Supplementary Concept]
- ethyl(5-((3-acetyl-1H-indol-1-yl)methyl)-2H-tetrazol-2-yl)acetate [MeSH Supplementary Concept]
- exforge HCT [MeSH Supplementary Concept]
- fentrazamide [MeSH Supplementary Concept]
- fimasartan [MeSH Supplementary Concept]
- forasartan [MeSH Supplementary Concept]
- losartan carboxylic acid [MeSH Supplementary Concept]
- mercuric-5-nitrotetrazole [MeSH Supplementary Concept]
- methyl (1-methyl-5-tetrazolyl)sulfonylacetate [MeSH Supplementary Concept]
- methyl-2-ethoxy-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-benzimidazole-7-carboxylate [MeSH Supplementary Concept]
- nojirimycin tetrazole [MeSH Supplementary Concept]
- olmesartan [MeSH Supplementary Concept]
- pentylenotetrazole [MeSH Supplementary Concept]
- picarbutrazox [MeSH Supplementary Concept]
- poly-N-(1H-tetrazole-5-yl)-methacrylamide [MeSH Supplementary Concept]
- pratosartan [MeSH Supplementary Concept]
- quinotolast [MeSH Supplementary Concept]
- renexin [MeSH Supplementary Concept]
- ro 106-9920 [MeSH Supplementary Concept]
- sacubitril and valsartan sodium hydrate drug combination [MeSH Supplementary Concept]
- tasosartan [MeSH Supplementary Concept]
- tazanolast [MeSH Supplementary Concept]
- tedizolid [MeSH Supplementary Concept]
- tetraniliprole [MeSH Supplementary Concept]
- tetrazene explosive [MeSH Supplementary Concept]
- tetrazolast [MeSH Supplementary Concept]
- tetrazolo(1,5-a)(1,4)benzodiazepine [MeSH Supplementary Concept]
- tetrazolo-oxo-purine nucleoside triphosphate [MeSH Supplementary Concept]
- tezampanel [MeSH Supplementary Concept]
- tezosentan [MeSH Supplementary Concept]
- trefentanil [MeSH Supplementary Concept]
- tribenzor [MeSH Supplementary Concept]
- vofopitant [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients